Denosumab usage is associated with better overall survival of patients with lung cancer and bone metastases: a retrospective cohort study
Denosumab usage, especially good compliance, for over five cycles in patients with lung cancer and bone metastases was associated with improved overall survival. Future studies should focus on strategies to improve adherence to denosumab treatment and maximise its clinical benefits.
Authors
- Jiun‐Ting Wu (ORCID: https://orcid.org/0000-0001-8430-894X)
- Ho-Sheng Lee (ORCID: https://orcid.org/0000-0001-5839-8670)
- Changmin Yu (ORCID: https://orcid.org/0000-0002-4890-8742)
- Chia-Chen Huang (ORCID: https://orcid.org/0000-0003-1289-4534)
- Jung Yueh Chen
Institutions
- E-Da Hospital (TW)
Publication Details
- Journal
- BMJ Open Respiratory Research
- Published
- 2025-12-01
- DOI
- https://doi.org/10.1136/bmjresp-2025-003173
- Citations
- 1
- Primary Topic
- Bone health and treatments
- Type
- article
- Field-Weighted Citation Impact
- 1.05